These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33081698)

  • 21. Bayesian B-spline mapping for dynamic quantitative traits.
    Xing J; Li J; Yang R; Zhou X; Xu S
    Genet Res (Camb); 2012 Apr; 94(2):85-95. PubMed ID: 22624568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Borrowing of strength from indirect evidence in 40 network meta-analyses.
    Lin L; Xing A; Kofler MJ; Murad MH
    J Clin Epidemiol; 2019 Feb; 106():41-49. PubMed ID: 30342086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Network Meta-analysis a Revolutionary Statistical Tool for Improving the Reliability of Clinical Trial Results? A Brief Overview and Emerging Issues Arising.
    Beis G; Papasotiriou I
    In Vivo; 2023; 37(3):972-984. PubMed ID: 37103082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of Bayesian and frequentist methods in random-effects network meta-analysis of binary data.
    Seide SE; Jensen K; Kieser M
    Res Synth Methods; 2020 May; 11(3):363-378. PubMed ID: 31955519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evidence-splitting approach to evaluation of direct-indirect evidence inconsistency in network meta-analysis.
    Shih MC; Tu YK
    Res Synth Methods; 2021 Mar; 12(2):226-238. PubMed ID: 33543575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Bayesian model for sparse functional data.
    Thompson WK; Rosen O
    Biometrics; 2008 Mar; 64(1):54-63. PubMed ID: 17573864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Network meta-analysis: development of a three-level hierarchical modeling approach incorporating dose-related constraints.
    Owen RK; Tincello DG; Keith RA
    Value Health; 2015 Jan; 18(1):116-26. PubMed ID: 25595242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Bayesian hierarchical model for network meta-analysis of multiple diagnostic tests.
    Ma X; Lian Q; Chu H; Ibrahim JG; Chen Y
    Biostatistics; 2018 Jan; 19(1):87-102. PubMed ID: 28586407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons.
    Hong H; Chu H; Zhang J; Carlin BP
    Res Synth Methods; 2016 Mar; 7(1):6-22. PubMed ID: 26536149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension.
    Thom HH; Capkun G; Cerulli A; Nixon RM; Howard LS
    BMC Med Res Methodol; 2015 Apr; 15():34. PubMed ID: 25887646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Network vs. pairwise meta-analyses: a case study of the impact of an evidence-synthesis paradigm on value of information outcomes.
    Zafari Z; Thorlund K; FitzGerald JM; Marra CA; Sadatsafavi M
    Pharmacoeconomics; 2014 Oct; 32(10):995-1004. PubMed ID: 24920194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bayesian multivariate network meta-analysis model for the difference in restricted mean survival times.
    Tang X; Trinquart L
    Stat Med; 2022 Feb; 41(3):595-611. PubMed ID: 34883534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bayesian Methods for Meta-Analyses of Binary Outcomes: Implementations, Examples, and Impact of Priors.
    Al Amer FM; Thompson CG; Lin L
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33801771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causal inference and adjustment for reference-arm risk in indirect treatment comparison meta-analysis.
    Swallow E; Patterson-Lomba O; Ayyagari R; Pelletier C; Mehta R; Signorovitch J
    J Comp Eff Res; 2020 Jul; 9(10):737-750. PubMed ID: 32490682
    [No Abstract]   [Full Text] [Related]  

  • 36. Checking consistency in mixed treatment comparison meta-analysis.
    Dias S; Welton NJ; Caldwell DM; Ades AE
    Stat Med; 2010 Mar; 29(7-8):932-44. PubMed ID: 20213715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian variable selection and estimation in semiparametric joint models of multivariate longitudinal and survival data.
    Tang AM; Zhao X; Tang NS
    Biom J; 2017 Jan; 59(1):57-78. PubMed ID: 27667731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing Bayesian and frequentist approaches for multiple outcome mixed treatment comparisons.
    Hong H; Carlin BP; Shamliyan TA; Wyman JF; Ramakrishnan R; Sainfort F; Kane RL
    Med Decis Making; 2013 Jul; 33(5):702-14. PubMed ID: 23549384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multilevel approach to network meta-analysis within a frequentist framework.
    Greco T; Edefonti V; Biondi-Zoccai G; Decarli A; Gasparini M; Zangrillo A; Landoni G
    Contemp Clin Trials; 2015 May; 42():51-9. PubMed ID: 25804722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence inconsistency degrees of freedom in Bayesian network meta-analysis.
    Lin L
    J Biopharm Stat; 2021 May; 31(3):317-330. PubMed ID: 33296239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.